PRIMECAP Management's position in Novartis AG is currently worth $1.13 Billion. That's 0.91% of their equity portfolio (30th largest holding). The first Novartis AG trade was made in Q1 2013. Since then PRIMECAP Management bought shares ten more times and sold shares on 38 occasions. The stake costed the investor $647 Million, netting the investor a gain of 74% so far.
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys...
Empire Financial Management Company LLC lessened its … shares during the quarter. Empire Financial Management Company LLC’s holdings …
… of two business units: Novartis Oncology and Novartis Pharmaceuticals . See Also Receive News … & Ratings for Novartis Daily - … and analysts'' ratings for...
Related Stocks: NIO , META , AMZN , NVS , TTM ,